COVID-19: The need for evidence-based medicine

A number of old drugs approved for other diseases are being “repurposed” and tested for their safety and efficacy in COVID-19, in systematic clinical trials. They have emergency approval for use in COVID-19, but most are not yet proven for this use. Some drugs have received approval without adequate testing. Other drugs are being used … Read the essay

Medical Conferences sans Drug Industry Sponsorship

Medical conferences are fast degenerating into melas that educate, entertain, amuse and irritate and deceive—not necessarily in that order. One can smell, see and feel the drug industry everywhere, advertising on the walls, shaping the contents and style of educational programmes, tempting with gifts and free meals, travel and other amenities. In 2003, MGIMS became … Read the essay

Ethical Challenges of Research in a Pandemic

The pressure for an effective treatment or vaccine for COVID-19 is high. There are more than 2,000 studies on COVID-19 across the world; many of these are trials on humans to develop vaccines, and to test the efficacy of drugs for this new disease. The urgency of this pandemic presents new, acute ethical challenges in … Read the essay

When is enough enough?

How do medical students learn to make impossible decisions every day? They can share their problems with their colleagues and seniors, and learn decision-making skills which will carry over into their practice once they graduate. At the MGIMS, a group of residents and interns has started informal discussions of case study scenarios. The idea is … Read the essay

Medical ethics beats drug company lures

The Academy of Medical Sciences, Nagpur organised a workshop on medical ethics on September 8 and 9, at the Udyog bhavan, Nagpur. Fed up with several ‘me too workshops’, the Academy wanted to do something different this year. Several doctors felt that medical ethics was a topic worth discussing in today’s times. However, some members … Read the essay